Your browser doesn't support javascript.
loading
Clinical, Genetic and Functional Characterization of a Novel AVPR2 Missense Mutation in a Woman with X-Linked Recessive Nephrogenic Diabetes Insipidus.
Selvaraj, Senthil; Rodrigues, Dírcea; Krishnamoorthy, Navaneethakrishnan; Fakhro, Khalid A; Saraiva, Luís R; Lemos, Manuel C.
Afiliación
  • Selvaraj S; Department of Genetics, Sidra Medicine, Doha P.O. Box 26999, Qatar.
  • Rodrigues D; Serviço de Endocrinologia, Diabetes e Metabolismo, Centro Hospitalar Universitário de Coimbra, 3000-075 Coimbra, Portugal.
  • Krishnamoorthy N; Department of Genetics, Sidra Medicine, Doha P.O. Box 26999, Qatar.
  • Fakhro KA; Department of Genetics, Sidra Medicine, Doha P.O. Box 26999, Qatar.
  • Saraiva LR; Department of Genetic Medicine, Weill Cornell Medical College, Doha P.O. Box 24144, Qatar.
  • Lemos MC; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha P.O. Box 24144, Qatar.
J Pers Med ; 12(1)2022 Jan 17.
Article en En | MEDLINE | ID: mdl-35055433
Nephrogenic diabetes insipidus (NDI) is a rare disorder characterized by renal unresponsiveness to the hormone vasopressin, leading to excretion of large volumes of diluted urine. Mutations in the arginine vasopressin receptor-2 (AVPR2) gene cause congenital NDI and have an X-linked recessive inheritance. The disorder affects almost exclusively male family members, but female carriers occasionally present partial phenotypes due to skewed inactivation of the X-chromosome. Here, we report a rare case of a woman affected with X-linked recessive NDI, presenting an average urinary output of 12 L/day. Clinical and biochemical studies showed incomplete responses to water deprivation and vasopressin stimulation tests. Genetic analyses revealed a novel heterozygous missense mutation (c.493G > C, p.Ala165Pro) in the AVPR2 gene. Using a combination of in-silico protein modeling with human cellular models and molecular phenotyping, we provide functional evidence for phenotypic effects. The mutation destabilizes the helical structure of the AVPR2 transmembrane domains and disrupts its plasma membrane localization and downstream intracellular signaling pathways upon activation with its agonist vasopressin. These defects lead to deficient aquaporin 2 (AQP2) membrane translocation, explaining the inability to concentrate urine in this patient.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Qatar Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Qatar Pais de publicación: Suiza